Does RAIT increase the risk of second primary malignancies in patients with PTC?
In patients with papillary thyroid cancer (PTC), radioactive iodine therapy (RAIT) does not appear to increase the risk of a second primary malignancy (SPM), reports a study. On the other hand, age and personal or family history of cancer are predictive of SPM in this population.